title: [Combined therapy of malignant testicular tumors].
abstract: The 5-year survival of patients with malignant testicular tumors rose during the past 25 years from 10-25% depending on stage to 55-100% after radical castration performed from high inguinal opening, retroperitoneal lymphadenectomy, ultra-tension irradiation and adjuvant chemotherapy. It is stressed that patients diagnosed at stage T1-2, N0-2, M0 may even recover perfectly upon complex therapy. Three to five-year long or even longer survival may be reached with 50% of the patients at the stage T1-3, N1-3, M1. Patients at stage T4, N3-4, M1 die because of the recurrence of the tumor and/or the complication of the adjuvant treatment within 1-3 years and even the interdisciplinary work which is very effective in other stages fails to change this at the present time.
authors.forename: J
authors.initials: J
authors.lastname: Pintér
authors.forename: I
authors.initials: I
authors.lastname: Bodrogi
authors.forename: J G
authors.initials: JG
authors.lastname: Pintér
authors.forename: V
authors.initials: V
authors.lastname: Szokoly
authors.forename: L
authors.initials: L
authors.lastname: Korányi
authors.forename: S
authors.initials: S
authors.lastname: Eckhardt
mesh_terms: D003131:Combined Modality Therapy; D004407:Dysgerminoma / Q000145:classification / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D013736:Testicular Neoplasms / Q000145:classification / Q000473:pathology / Q000628:therapy*
vernacular_title: A rosszindulatú heredaganatok komplex kezelése.